To explore its mechanisms in CRC, HD6 may compete with the interaction between epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) and cause a reduction of serpine-1 expression in CRC cells. This evidence concerns the gene EGF and colorectal carcinoma.